Article
Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker.
PloS one - 20 Dec 2010
Tong Yu K, Chiu Rossa W K, Akolekar Ranjit, Leung Tak Y, Lau Tze K, Nicolaides Kypros H, Lo Y M Dennis
Abstract excerpt
BACKGROUND: The putative promoter of the holocarboxylase synthetase (HLCS) gene on chromosome 21 is hypermethylated in placental tissues and could be detected as a fetal-specific DNA marker in maternal plasma. Detection of fetal trisomy 21 (T21) has been demonstrated by an epigenetic-genetic chromosome dosage approach where the amount of hypermethylated HLCS in maternal plasma is normalized using a fetal genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
